Prevention of Persistent Opioid Use in Mothers

Opioid Use Clinical Trial

Official title: Prevention of Persistent Pain and Opioid Use in Mothers - POMS

Status Completed

Clinical Trial Summary

Our previous work has identified the group of women at risk for prolonged pain, opioid use and poor functional recovery after childbirth. The optimal intervention to mitigate this risk is unknown. We propose to test an analgesic adjutant that is commonly used for post-operative pain compared to placebo to improve post-partum recovery.

Clinical Trial Description

A small percent of the large population of women who give birth have difficulty with prolonged pain, opioid use and poor functional recovery. This may be the first opiate exposure and significant health challenge in a young woman's life.

In our previous work, we have identified 20% who are at highest risk for prolonged pain and delayed opioid cessation and functional recovery with usual care. Moderate to severe pain on postpartum day 1 is a significant predictor of being in the risk group. The optimal intervention to mitigate this risk is unknown.

We plan to test an intervention of low dose gabapentin or placebo to be escalated by a pain medicine doctor as needed. We hypothesize that additional care of women predicted to be higher need by virtue of their postoperative day one pain score (> 6 x2) despite usual multimodal analgesic care will lead to reduced need for opioid, less pain and more rapid functional recovery. ;

Related Conditions & MeSH terms

• Chronic Pain
• Chronic Pain Syndrome
• Opioid Use
• Postpartum Disorder
• Puerperal Disorders

• NCT number: NCT03472521
• Study type: Interventional
• Source: Stanford University
• Status: Completed
• Phase: Phase 4
• Start date: September 17, 2018
• Completion date: April 10, 2021